Butterfly NetworkFRA:7JA +1.63%40 EBIT per Share is €-0.25 as of Mar. 2026. GuruFocus rates FRA:7JA with a GF Score™ of 40/100 and a GF Value™ of €2.00 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 687 Medical Devices & Instruments companies, Butterfly Network ranks better than 73.8% on this metric.
Butterfly Network's EBIT per Share for the
three
months ended in Mar. 2026 was €-0.04.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.25.
During the past 3 years, the average EBIT per Share Growth Rate was 28.70% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 51.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Butterfly Network's EBIT per Share or its related term are showing as below:
FRA:7JA'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 28.7 Med: 46.65 Max: 70.2
Current: 28.7
During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of Butterfly Network was 70.20% per year. The lowest was 28.70% per year. And the median was 46.65% per year.
FRA:7JA's 3-Year EBIT Growth Rate is ranked better than 73.8% of 687
companies
in the Medical Devices & Instruments industry
Industry Median: 9.4
vs FRA:7JA: 28.70
Butterfly Network (FRA:7JA) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Butterfly Network EBIT per Share Related Terms
Butterfly Network EBIT per Share Historical Data
* Premium members only.
The historical data trend for Butterfly Network's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.25
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Butterfly Network (FRA:7JA) has a EBIT per Share of €-0.25 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Butterfly Network and its competitors. According to the industry distribution chart, Butterfly Network ranks #180 out of 687 companies in the Medical Devices & Instruments industry, placing it in the top 26.2%.
Is Butterfly Network's EBIT per Share too high?
Butterfly Network's current EBIT per Share is €-0.25. Based on the distribution chart, Butterfly Network ranks #180 out of 687 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Butterfly Network has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Butterfly Network's EBIT per Share compare to TMDX and AXGN?
According to the Medical Devices & Instruments industry distribution chart, Butterfly Network ranks #180 out of 687 companies for EBIT per Share. This puts Butterfly Network in the upper half of its industry. The industry median EBIT per Share is 9.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.40, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Butterfly Network and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Butterfly Network's current EBIT per Share is €-0.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Butterfly Network stock overvalued right now?
Based on GuruFocus' analysis, Butterfly Network (FRA:7JA) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.00, compared to a current price of €7.18 — trading 259% above its estimated fair value. The current EBIT per Share is €-0.25. Butterfly Network's overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Butterfly Network (FRA:7JA), the current EBIT per Share is €-0.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Butterfly Network (FRA:7JA) Overvalued in 2026?
Based on GuruFocus' analysis, Butterfly Network stock appears to be overvalued.
The current stock price of €7.18 is trading 259% above its estimated GF Value™ of €2.00.
GuruFocus considers Butterfly Network to be Significantly Overvalued.
Key valuation signals for FRA:7JA:
EBIT per Share: €-0.25
GF Value™: €2.00 vs. price of €7.18 (259% above fair value)
No single metric tells the full story. See the FRA:7JA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. The company operates in one reportable segment, which includes all activities related to the development, manufacture, and sale of the Company's products, software, and other services.
40GF Score
Get the complete analysis for FRA:7JA
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7JA has been successfully added to your 
